Company intelligence / Profile preview

Laboratorio Libra

Montevideo, Montevideo Department, Uruguaylablibra.com ↗
Ownership
Private
Employees
~102
Development stage
Commercial
01

Overview

Laboratorio Libra has over fifty years of experience producing and exporting pharmaceutical products. The company operates internationally with a focus on Latin America and has established partnerships for the exclusive marketing of CNS drugs in Chile. It maintains a strong commitment to quality and environmental responsibility.

Therapeutic areas
OtherPsychiatryRheumatologyNeurologyInfectious Diseases
Modalities
Small molecules
Industry
Biotech
02

Drug pipeline

3 assets

lenalidomide

Commercial
Indications
Oncology

2 more assets in the full pipeline.

03

Partnerships

Luye Pharma Group – exclusive marketing rights for Seroquel/Seroquel XR in Chile

Beyond the preview

Go deeper on Laboratorio Libra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratorio Libra.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call